Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Neoplasms”

1,947 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,947 results

Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00275262
What this trial is testing

Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+1 more
Abbott 25
Not applicableLooking for participantsNCT05641961
What this trial is testing

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Who this might be right for
Childhood CancerHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 30
Not applicableLooking for participantsNCT05921318
What this trial is testing

Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
Peking University People's Hospital 20
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Not applicableStudy completedNCT04630015
What this trial is testing

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 134
Testing effectiveness (Phase 2)Study completedNCT01086735
What this trial is testing

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Malignancy
Assistance Publique - Hôpitaux de Paris 11
Early research (Phase 1)Looking for participantsNCT06440135
What this trial is testing

Ziftomenib Maintenance Post Allo-HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionNPM1 Mutation+1 more
Massachusetts General Hospital 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT06673459
What this trial is testing

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

Who this might be right for
T-Cell Lymphocytic LeukemiaALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONTotal Body Irradiation+1 more
The First Affiliated Hospital of Soochow University 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Large-scale testing (Phase 3)Study completedNCT02696408
What this trial is testing

Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation

Who this might be right for
Hematologic Malignancy
Institut de Cancérologie de la Loire 234
Testing effectiveness (Phase 2)Ended earlyNCT00593554
What this trial is testing

Phase 2 Haplotype Mismatched HSCT in Patients With Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplasia+1 more
Sherif S. Farag 9
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Early research (Phase 1)Active Not RecruitingNCT00840853
What this trial is testing

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma
Baylor College of Medicine 68
Not applicableStudy completedNCT01081405
What this trial is testing

Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
HEMATOLOGIC MALIGNANCIES
Fondazione EMN Italy Onlus 20
Testing effectiveness (Phase 2)Study completedNCT00357565
What this trial is testing

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesChildhood Acute Myeloid Leukemia in Remission+10 more
Masonic Cancer Center, University of Minnesota 34
Not applicableUnknownNCT05156554
What this trial is testing

PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation

Who this might be right for
Lymphoma
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Study completedNCT02663622
What this trial is testing

Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

Who this might be right for
Graft Versus Host DiseaseHematopoietic Stem Cell TransplantationLeukemia
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 44
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Early research (Phase 1)Looking for participantsNCT03802695
What this trial is testing

Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMixed Phenotype Acute Leukemia+1 more
Orca Biosystems, Inc. 300
Load More Results